Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Revenue (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Revenue for 16 consecutive years, with $13.7 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 31.08% to $13.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44.5 million through Dec 2025, up 17.57% year-over-year, with the annual reading at $44.5 million for FY2025, 17.57% up from the prior year.
  • Revenue hit $13.7 million in Q4 2025 for Cumberland Pharmaceuticals, up from $8.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $13.7 million in Q4 2025 to a low of $8.1 million in Q3 2021.
  • Historically, Revenue has averaged $10.0 million across 5 years, with a median of $10.0 million in 2023.
  • Biggest five-year swings in Revenue: decreased 18.92% in 2021 and later soared 41.38% in 2022.
  • Year by year, Revenue stood at $8.3 million in 2021, then increased by 9.66% to $9.1 million in 2022, then increased by 2.51% to $9.4 million in 2023, then rose by 11.57% to $10.4 million in 2024, then soared by 31.08% to $13.7 million in 2025.
  • Business Quant data shows Revenue for CPIX at $13.7 million in Q4 2025, $8.3 million in Q3 2025, and $10.8 million in Q2 2025.